2 active not recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
Follow Hypergammaglobulinemia: new trials by email Literature Review of Hypergammaglobulinemia trials Research Report on Hypergammaglobulinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Clinical Observation, Lenalidomide, Quality-of-Life Assessment - Light Chain Deposition Disease, Smoldering Multiple Myeloma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 226 | 2011-01-24 | 2026-10-01 |
| Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant Autologous Hematopoietic Stem Cell Transplantation, Laboratory Biomarker Analysis, Lenalidomide - DS Stage I Multiple Myeloma, DS Stage II Multiple Myeloma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 460 | 2004-12-15 | 2026-08-26 |
Smoldering Multiple Myeloma (2) · Multiple Myeloma (1)
Blood Protein Disorders (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Neoplasms (2) · Paraproteinemias (2) · Precancerous Conditions (2) · Cardiovascular Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Lymphoproliferative Disorders (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1)
Lenalidomide (2) · Melphalan (1) · Observation (1) · Peripheral Blood Stem Cell Transplantation (1) · Stem Cell Transplantation (1) · Watchful Waiting (1)
National Cancer Institute (NCI) (2)
United States (2) · Ireland (1) · Puerto Rico (1)
Philip L McCarthy (1) · Sagar Lonial (1)
PMID 22571201, PMID 28826616, PMID 31652094
U10CA021115 (1), U10CA031946 (1), U10CA180820 (1), U10CA180821 (1), U24CA196172 (1)